Patents by Inventor Henry C. Padgett

Henry C. Padgett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7928210
    Abstract: Disclosed herein are novel radiolabeled nucleosides and methods for detecting cellular proliferation in a mammal, the method comprising administrating an effective amount of a radiolabeled nucleoside; the method comprising: a) administering to the mammal a diagnostically effective amount of the nucleoside to the mammal; b) allowing the nucleoside to distribute into the effective tissue; and c) imaging the tissue, wherein an increase in binding of the compound to tissue compared to a normal control level of binding indicates that the mammal is suffering from a disease involving cellular proliferation.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: April 19, 2011
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Hartmuth C. Kolb, Joseph C. Walsh, Robert M Yeh, Kai Chen, Umesh Gangadharmath, Brian Duclos, Vani P. Mocharla, Farhad Karimi, Henry C. Padgett, Qianwa Liang, Tieming Zhao
  • Publication number: 20090016958
    Abstract: Disclosed herein are novel radiolabeled nucleosides and methods for detecting cellular proliferation in a mammal, the method comprising administrating an effective amount of a radiolabeled nucleoside; the method comprising: a) administering to the mammal a diagnostically effective amount of the nucleoside to the mammal; b) allowing the nucleoside to distribute into the effective tissue; and c) imaging the tissue, wherein an increase in binding of the compound to tissue compared to a normal control level of binding indicates that the mammal is suffering from a disease involving cellular proliferation.
    Type: Application
    Filed: March 3, 2008
    Publication date: January 15, 2009
    Inventors: Hartmuth C. Kolb, Joseph C. Walsh, Robert M. Yeh, Kai Chen, Umesh Gangadharmath, Brian Duclos, Vani P. Mocharla, Farhad Karimi, Henry C. Padgett, Qianwa Liang, Tieming Zhao
  • Patent number: 7419653
    Abstract: The invention is a method and related precursor for preparing 18F-FLT. The precursor has a butoxycarbonyl protecting group at the 5?-position that results in low amounts of chromophoric byproducts being formed during deprotection. The method for preparing 18F-FLT is efficient and makes the final purification step less complicated.
    Type: Grant
    Filed: November 22, 2006
    Date of Patent: September 2, 2008
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Joseph C. Walsh, Henry C. Padgett, Tanea Ysaguirre
  • Patent number: 7160537
    Abstract: The invention is a method and related precursor for preparing 18F-FLT. The precursor has a butoxycarbonyl protecting group at the 5?-position that results in low amounts of chromophoric byproducts being formed during deprotection. The method for preparing 18F-FLT is efficient and makes the final purification step less complicated.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: January 9, 2007
    Assignee: Siemens Medical Solutions USA, Inc.
    Inventors: Joseph C. Walsh, Henry C. Padgett, Tanea Ysaguirre
  • Patent number: 7022872
    Abstract: The invention relates to a method for preparing F-Dopa and 18F-Dopa and intermediates that are useful in the method. The invention is a method that synthesizes F-Dopa and 18F-Dopa in good yield with high enantiopurity without the need for further transformations. The method includes the step of reacting a benzaldehyde derivative with a phosphonic acid derivative to produces an olefin intermediate that can be asymmetrically hydrogenated to produce the desired enantiomer.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: April 4, 2006
    Assignee: Molecular Technologies, Inc.
    Inventors: Joseph C. Walsh, Henry C. Padgett
  • Publication number: 20040258615
    Abstract: The invention provides a method and apparatus for preparation of radiochemicals wherein the reaction that couples the radioactive isotope to the reactive precursor to form a positron-emitting molecular imaging probe is performed in a microfluidic environment.
    Type: Application
    Filed: April 20, 2004
    Publication date: December 23, 2004
    Applicant: Molecular Technologies, Inc.
    Inventors: Charles Russell Buchanan, Henry C. Padgett, Thomas Lee Collier, Joseph C. Matteo, Charles W. Alvord
  • Patent number: 5345477
    Abstract: A system and process for the production of nitrogen-13 ammonium ions from a target material in the form of a dilute solution of ethanol in natural water by the reaction of protons with oxygen-16 within the target material. The system includes a device for producing a proton beam which travels along a preselected path and strikes the target material in a target chamber. This target chamber is positioned in the path of the proton beam such that subjection of the target material to the beam produces nitrogen-13 atoms in a predetermined form. These nitrogen-13 atoms are converted in the aqueous solution to ammonium, ions and oxides and are conducted from the target holder to a purification device for collecting a purified product containing such ammonium ions. A cooling system serves to dissipate heat generated during the production of the nitrogen-13 atoms by the reaction of protons with the oxygen. Other solutes for the target material are discussed.
    Type: Grant
    Filed: June 19, 1991
    Date of Patent: September 6, 1994
    Assignee: CTI Cyclotron Systems, Inc.
    Inventors: Bruce W. Wieland, Gerald T. Bida, George O. Hendry, Henry C. Padgett